Pfizer Pregabalin NDA Will Include Anxiety Use; Filing Date Pushed To 2002

Pfizer's updated pregabalin NDA filing schedule calls for three initial indications - add-on epilepsy, neuropathic pain and generalized anxiety disorder - to be submitted in 2002